Moreover, recent multi-cohort proteomics studies of CSF using data-independent acquisition MS, coupled with machine learning, have identified subtype specific protein classifiers of AD that differentiate between Aβ+/tau+ and Aβ+/tau− individuals [213]. The gene discussed is MAPT; the disease is Alzheimer disease.